Caribou Biosciences, Inc.
Caribou Biosciences, Inc.（CRBU）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
crbu · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 9 位华尔街分析师
Buy
9 位分析师
共识
评级分布
12 个月目标价
High
$7.00
Consensus
$5.00
+171.7% upside
Low
$3.00
Median: $5 · Last Close: $1.84
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$5.00
171.7% upside
High Target
$7
280.4%
Low Target
$3
63.0%
Current Price
$1.84
as of today
Based on analyst price targets, the CRBU stock price prediction for the next 12 months ranges from $3 to $7. The consensus CRBU price forecast of $5.00 implies 171.7% upside from the current price of $1.84.
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.80 | ↓ 2.32% |
1-day model range: $1.76–$1.83. Peak: $1.83 (-2.32%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · CRBU · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-09 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2025-11-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-03 | Citigroup | Maintains | Buy→Buy |
| 2025-04-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-07 | B of A Securities | Maintains | Buy→Buy |
| 2024-11-26 | Citigroup | Maintains | Buy→Buy |
| 2024-11-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Caribou Biosciences, Inc. (CRBU) stock. Of the recent 40 rating actions, 1 were upgrades and 0 were downgrades. 9 analysts currently cover CRBU.
分析师推荐趋势
CRBU analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$24M
↓ 22.5% YoY
Revenue Next Year
$27M
↑ 14.6% YoY
EPS This Year
$-1.16
EPS Next Year
$-1.28
↑ 11.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast CRBU EPS of $-1.16 for the current fiscal year, based on estimates from 3 analysts. The CRBU revenue forecast is $24M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CRBU 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CRBU 的共识目标价为 $5.00（+171.7% 上行空间），分析师共识为 Buy。
CRBU 的短期预测（明日）为 $1.80（-2.32%）。 CRBU 对 2030 年的预测区间为 $1–$1。
Caribou Biosciences, Inc. 在 NASDAQ 上市，代码 CRBU。CRBU 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
CRBU 预测 · 8 个问题根据 9 位华尔街分析师，CRBU 的 12 个月平均目标价为 $5.00，最高 $7.00、最低 $3.00。若有图表，中位目标价可在上方查看。相对当前价 $1.84，隐含约 +171.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.